Unresectable, locally advanced Cholangiocarcinomas

DrugDrug NameDrug Description
DB11886InfigratinibAn FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement.
DB15102PemigatinibA kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients.
DrugDrug NameTargetType
DB11886InfigratinibCytochrome P450 3A4enzyme
DB11886InfigratinibMultidrug and toxin extrusion protein 1transporter
DB11886InfigratinibATP-binding cassette sub-family G member 2transporter
DB11886InfigratinibBile salt export pumptransporter
DB11886InfigratinibSolute carrier family 22 member 1transporter
DB11886InfigratinibSolute carrier family 22 member 2transporter
DB11886InfigratinibMultidrug and toxin extrusion protein 2transporter
DB11886InfigratinibP-glycoprotein 1transporter
DB11886InfigratinibSolute carrier organic anion transporter family member 1B1transporter
DB11886InfigratinibSolute carrier organic anion transporter family member 1B3transporter
DB11886InfigratinibApolipoproteinscarrier
DB11886InfigratinibDimethylaniline monooxygenase [N-oxide-forming] 3enzyme
DB11886InfigratinibFibroblast growth factor receptor 1target
DB11886InfigratinibFibroblast growth factor receptor 2target
DB11886InfigratinibFibroblast growth factor receptor 3target
DB11886InfigratinibFibroblast growth factor receptor 4target
DB15102PemigatinibCytochrome P450 3A4enzyme
DB15102PemigatinibFibroblast growth factor receptor 1target
DB15102PemigatinibFibroblast growth factor receptor 2target
DB15102PemigatinibFibroblast growth factor receptor 3target
DB15102PemigatinibFibroblast growth factor receptor 4target
DB15102PemigatinibP-glycoprotein 1transporter
DB15102PemigatinibATP-binding cassette sub-family G member 2transporter
DB15102PemigatinibSolute carrier family 22 member 2transporter
DB15102PemigatinibMultidrug and toxin extrusion protein 1transporter
DrugDrug NamePhaseStatusCount